58 results
Page 3 of 3
424B5
1brk 1wspre7e085
27 Jun 18
Prospectus supplement for primary offering
9:30am
6-K
EX-99.1
f5sbkin hwytij
23 Oct 17
VBL Therapeutics Celebrates Opening of its New Gene Therapy Manufacturing Plant and Company Headquarters
12:00am
6-K
EX-99.1
bcn2v
20 Oct 17
VBL Therapeutics Announces Orphan Drug Designation for VB-111 In Europe
12:00am
20-F
EX-4.18
zri94 6d06h34gslbk5n
25 Mar 15
Annual report (foreign)
12:00am
20-F
gfs 1cf8lx
25 Mar 15
Annual report (foreign)
12:00am
S-8
EX-4.4
iz5yer
3 Mar 15
Registration of securities for employees
12:00am
424B4
osj8ey ga6
2 Oct 14
Prospectus supplement with pricing info
12:00am
424B4
zq91exyspn3
1 Aug 14
Prospectus supplement with pricing info
12:00am
F-1/A
EX-10.13
3voy8fc0bpshl
18 Jul 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.10
h5fj 3x934l3l99w
18 Jul 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.3
fbvs5q 8akgrqg9
18 Jul 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.12
1vea443
18 Jul 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.11
pj010mc6iujf
18 Jul 14
Registration statement (foreign) (amended)
12:00am